Age at First Measles-Mumps-Rubella Vaccination in Children with Autism and School-Matched Control Subjects: A Population-Based Study in Metropolitan Atlanta

Pediatrics

Volumn 113, Issue 2, 2004, Pages 259-266

  DeStefano, Frank ^a,c   Bhasin, Tanya Karapurkar ^b   Thompson, William W ^a   Yeargin Allsopp, Marshalyn ^c   Boyle, Coleen ^c  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Autism; Autism spectrum disorders; Epidemiology; Immunizations; MMR vaccine

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

AGE DISTRIBUTION; ARTICLE; AUTISM; CHILD; CONTROLLED STUDY; FEMALE; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; MUMPS; PRIORITY JOURNAL; RUBELLA; URBAN POPULATION;

AGE DISTRIBUTION; AUTISTIC DISORDER; BIRTH WEIGHT; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CONTINENTAL POPULATION GROUPS; DEVELOPMENTAL DISABILITIES; FEMALE; GEORGIA; HUMANS; INFANT; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MENTAL RETARDATION; ODDS RATIO; POPULATION SURVEILLANCE; RISK FACTORS; VACCINATION;

EID: 0842324924     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.113.2.259     Document Type: Article

References (48)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994
2. Baird G, Charman T, Baron-Cohen S, et al. A screening instrument for autism at 18 months of age: a 6-year follow-up study. J Am Acad Child Adolesc Psychiatry. 2000;39:694-702
3. Bertrand J, Mars A, Boyle C, Bove F, Yeargin-Allsopp M, Decoufle P. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics. 2001;108:1155-1161
4. Chakrabarti S, Fornbonne E. Pervasive developmental disorders in preschool children. JAMA. 2001;285:303-309
5. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. The prevalence of autism: Metropolitan Atlanta. JAMA. 2003;289:49-55
6. Bohman M, Bohman I, Bjorck P, et al. Childhood psychosis in a northern Swedish county: some preliminary findings from an epidemiological survey. In: Schmidt M, Remschmidt H, eds. Epidemiological Approaches in Child Psychiatry: II. New York, NY: Thieme-Stratton; 1983:164-173
7. McCarthy P, Fitzgerald M, Smith M. Prevalence of childhood autism in Ireland. Irish Med J. 1984;77:129-130
8. Gillberg C. Infantile autism and other childhood psychoses in a Swedish urban region: epidemiological aspects. J Child Psychol Psychiatry. 1984;25:45-43
9. Steinhausen H, Gobel D, Breinlinger M, et al. A community survey of infantile autism. J Am Acad Child Psychiatry. 1986;25:186-189
10. Fornbonne E. Epidemiological trends in rates of autism. Mol Psychiatry. 2002;7:S4-S6
11. US Department of Education, Office of Special Education Programs, Data Analysis System (DANS). Number of Children Served Under IDEA by Disability and Age Group, During the 1989-90 Through 1998-1999 School Years. Twenty-Second Annual Report to Congress on the Implementation of the Individuals with Disabilities Education Act. Washington, DC: US Department of Education; 2000:11-20
12. California Health and Human Services Agency, Department of Developmental Services. Changes in the Population of Persons With Autism and Pervasive Developmental Disorders in California's Developmental Services System: 1987 Through 1998: A Report to the Legislature, March 1, 1999. Sacramento, CA: California Health and Human Services Agency; 1999
13. Croen L, Grether J, Hoogstrate J, Selvin S. The changing prevalence of autism in California. J Autism Dev Dis. 2002;32:207-215
14. Byrd RS. Report to the legislature on the principal findings from the epidemiology of autism in California: a comprehensive pilot study. Davis, CA: M.I.N.D. Institute, University of California, Davis; 2002. Available at: mindinstitute.ucdmc.ucdavis.edu/news/study_final.pdf
15. Wakefield AJ, Murch S, Anthony A, et al. Ileal lymphoid nodular hyperplasia, non-specific colitis, and regressive developmental disorder in children. Lancet. 1998;351:637-641
16. Wakefield AJ, Anthony A, Murch S, et al. Enterocolitis in children with developmental disorders. Am J Gastroenterol. 2000;95:2285-2295
17. Kawashimi H, Takayuki M, Kashiwagi Y, Takekuma K, Akinori H, Wakefield A. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig Dis Sci. 2000;45:723-729
18. Uhlmann V, Martin CM, Sheils O, et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol. 2002;55:34-90
19. Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization coverage in California. JAMA. 2001;285:1183-1185
20. Farrington CP, Miller E, Taylor B. MMR and autism: further evidence against a causal association. Vaccine. 2001;19:3632-3635
21. Gillberg C, Heijbel H. MMR and autism. Autism. 1998;2:423-424
22. Kaye JA, del Mar Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. Br Med J. 2001;322:460-463
23. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999;353:2026-2029
24. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med. 2002;347:1477-1482
25. Stratton K, Gable A, McCormick M, eds. Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism. Washington, DC: National Academy Press; 2001
26. Yeargin-Allsopp M, Murphy C, Oakley G, Sikes K. A multiple-source method for studying the prevalence of developmental disabilities in children: the Metropolitan Atlanta Developmental Disabilities Study. Pediatrics. 1992;89:624-630
27. Edmonds LD, Layde PM, James LM, Flynt JW, Erickson JD, Oakley JP Jr. Congenital malformations surveillance: two American systems. J Epidemiol. 1981;10:247-252
28. Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1998;47(RR-8):1-57
29. Fornbonne E. Is there an epidemic of autism? Pediatrics. 2001;107:411-412
30. Short AB, Schopler E. Factors relating to age of onset in autism. J Autism Dev Dis. 1988;18:207-216
31. De Giacomo A, Fornbonne E. Parental recognition of developmental abnormalities in autism. Eur Child Adolesc Psychiatry. 1998;7:131-136
32. Volkmar FR, Stier DM, Cohen DJ. Age of recognition of pervasive developmental disorder. Am J Psychiatry. 1985;142:1450-1452
33. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138:923-936
34. Rodier PM, Hyman SL. Early environmental factors in autism. Ment Retard Dev Dis Res Rev. 1998;4:121-128
35. Kemper TL, Bauman M. Neuropathology of infantile autism. J Neuropathol Exp Neurol. 1998;57:645-652
36. Nelson KB, Grether JK, Croen LA, et al. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol. 2001;49:597-606
37. Osterling J, Dawson G. Early recognition of children with autism: a study of first birthday home videotapes. J Autism Dev Dis. 1994;24:247-257
38. Werner E, Dawson G, Osterling J, Dinno N. Recognition of autism spectrum disorder before one year of age: a retrospective study based on home videotapes. J Autism Dev Dis. 2000;30:157-162
39. Filipek PA, Accardo PJ, Ashwal S, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Dis. 1999;29:439-484
40. Fornbonne E, Chakrabarti S. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics. 2001;108(4). Available at: www.pediatrics.org/cgi/content/full/108/4/e58
41. Lord C. Follow-up of two-year-olds referred for possible autism. J Child Psychol Psychiatry. 1995;36:1365-1382
42. Shinnar S, Rapin I, Arnold S, et al. Language regression in childhood. Pediatr Neurol. 2001;24:183-189
43. Tuchman RF, Rapin I. Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics. 1997;99:560-566
44. Medical Research Council. MRC review of autism research: epidemiology and causes; 2001. Available at: www.mrc.ac.uk/pdf-autism-report.pdf
45. Halsey NA, Hyman SL, the Conference Writing Panel. Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunization Conference convened in Oak Brook, Illinois June 12-13, 2000. Pediatrics. 2001;107(5). Available at: www.pediatrics.org/cgi/content/full/107/5/e84
46. Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ. 2002;324:393-396
47. Black C, Kay JA, Jick H. Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. BMJ. 2002;325:419-421
48. Wakefield AJ, Montgomery SM. Measles, mumps, rubella vaccine: through a glass darkly. Adverse Drug Res. 2000;19:1-19